Log In
Print
BCIQ
Print
Print this Print this
 

CSL112

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionPurified apolipoprotein A-1 (APOA1) reconstituted to form HDL for IV infusion
Molecular Target Apolipoprotein A-1 (APOA1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAcute coronary syndrome
Indication DetailsPrevent cardiovascular events in adults with acute coronary syndrome (ACS); Treat acute coronary syndrome (ACS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today